The Comparative Analysis of the Effects on Plaque Volume and Tissue Characteristics Between Combined Therapy With STAatin Plus FENOfibrate and Statin Alone in Mild to Moderate, Non- Intervened Coronary Artery Stenosis (STAFENO Trial)
Phase of Trial: Phase III
Latest Information Update: 29 Aug 2016
At a glance
- Drugs Fenofibrate (Primary) ; Rosuvastatin
- Indications Coronary artery disease
- Focus Therapeutic Use
- Acronyms STAFENO
- 22 Aug 2016 Planned number of patients changed from 200 to 160.
- 22 Aug 2016 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 22 Aug 2016 Planned primary completion date changed from 1 Jul 2017 to 1 Dec 2018.